Platelet Activation in Multiple Sclerosis
Author Information
Author(s): Sheremata William A, Jy Wenche, Horstman Lawrence L, Ahn Yeon S, Alexander J Steven, Minagar Alireza
Primary Institution: Multiple Sclerosis Center and Department of Neurology, Miller School of Medicine, University of Miami
Hypothesis
Are platelets activated in multiple sclerosis patients?
Conclusion
Platelets are significantly activated in MS patients.
Supporting Evidence
- Platelet microparticles were significantly elevated in MS patients compared to controls.
- CD62p expression was markedly elevated in MS patients.
- Platelet-associated IgM was marginally elevated in MS patients.
Takeaway
This study found that people with multiple sclerosis have very active platelets, which might be important for understanding their condition.
Methodology
The study involved 33 stable, untreated MS patients and 92 normal controls, measuring various platelet activation markers.
Limitations
The study was not longitudinal, so it is unclear if elevated platelet activation is consistent across all MS patients.
Participant Demographics
33 treatment-naïve, clinically stable relapsing-remitting MS patients and 92 normal controls.
Statistical Information
P-Value
p < 0.001 for PMP and CD62p; p = 0.01 for PAg; p = 0.01 for platelet-associated IgM.
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website